» Articles » PMID: 19553527

IL-17 and IFN-gamma Mediate the Elicitation of Contact Hypersensitivity Responses by Different Mechanisms and Both Are Required for Optimal Responses

Overview
Journal J Immunol
Date 2009 Jun 26
PMID 19553527
Citations 52
Authors
Affiliations
Soon will be listed here.
Abstract

Hapten-induced contact hypersensitivity (CHS) in the skin is a delayed type cellular immune response that can be mediated by CD8(+) T cells that produce IFN-gamma or IL-17. However, mechanisms for these cytokines in the elicitation of CHS remain to be fully elucidated. In this study, we show that adoptive transfer of CHS with hapten-primed wild-type (WT) CD8(+) T cells is reduced in IFN-gammaR(-/-) or IL-17R(-/-) mice compared with WT controls. The infiltration of granulocytes and macrophages in the hapten challenged skin of IL-17R(-/-) recipients is significantly reduced whereas it is less affected in IFN-gammaR(-/-) recipients although CD8(+) T cell infiltration is inhibited in both recipients. In contrast, the activity of reactive oxidative species is significantly inhibited in IFN-gammaR(-/-) but is less affected in IL-17R(-/-) recipients. Further analysis reveals that the expression of chemokines and cytokines is differentially regulated in the hapten-challenged skin of IFN-gammaR(-/-) or IL-17R(-/-) recipients compared with WT controls. Interestingly, injection of rIL-17 in the skin induces inflammation with a high level of leukocyte infiltration whereas injection of IFN-gamma induces inflammation with a high level of reactive oxidative species. Moreover, neutralization of IL-17 in IFN-gammaR(-/-) or IFN-gamma in IL-17R(-/-) mice further suppresses the adoptive transfer of CHS by hapten-primed WT CD8(+) T cells. The study demonstrates that IFN-gamma and IL-17 mediate the elicitation of CHS by different mechanisms and that both cytokines are required for optimal responses. This outcome improves understanding of pathogenesis and provides new insights into therapeutic strategies for CHS.

Citing Articles

Ultraviolet Radiation-Induced Tolerogenic Dendritic Cells in Skin: Insights and Mechanisms.

Ghajar-Rahimi G, Yusuf N, Xu H Cells. 2025; 14(4).

PMID: 39996779 PMC: 11854269. DOI: 10.3390/cells14040308.


Proton pump inhibitor alters Th17/Treg balance and induces gut dysbiosis suppressing contact hypersensitivity reaction in mice.

Strzepa A, Marcinska K, Kiecka A, Majewska-Szczepanik M, Szczepanik M Front Immunol. 2024; 15:1390025.

PMID: 39247190 PMC: 11377960. DOI: 10.3389/fimmu.2024.1390025.


Helper T cell subsets: Development, function and clinical role in hypersensitivity reactions in the modern perspective.

Kan A, Tang W, Li P Heliyon. 2024; 10(9):e30553.

PMID: 38726130 PMC: 11079302. DOI: 10.1016/j.heliyon.2024.e30553.


Berry Extracts and Their Bioactive Compounds Mitigate LPS and DNFB-Mediated Dendritic Cell Activation and Induction of Antigen Specific T-Cell Effector Responses.

Upadhaya P, Lamenza F, Shrestha S, Roth P, Jagadeesha S, Pracha H Antioxidants (Basel). 2023; 12(9).

PMID: 37759970 PMC: 10525528. DOI: 10.3390/antiox12091667.


The Role of Microbiota-Derived Vitamins in Immune Homeostasis and Enhancing Cancer Immunotherapy.

Gholami H, Chmiel J, Burton J, Maleki Vareki S Cancers (Basel). 2023; 15(4).

PMID: 36831641 PMC: 9954268. DOI: 10.3390/cancers15041300.


References
1.
Xu H, Bjarnason B, Elmets C . Sensitization versus elicitation in allergic contact dermatitis: potential differences at cellular and molecular levels. Am J Contact Dermat. 2000; 11(4):228-34. DOI: 10.1053/ajcd.2000.8009. View

2.
Aggarwal S, Gurney A . IL-17: prototype member of an emerging cytokine family. J Leukoc Biol. 2002; 71(1):1-8. View

3.
Reeve V, Bosnic M, Nishimura N . Interferon-gamma is involved in photoimmunoprotection by UVA (320-400 nm) radiation in mice. J Invest Dermatol. 1999; 112(6):945-50. DOI: 10.1046/j.1523-1747.1999.00594.x. View

4.
Adachi Y, Kindzelskii A, Petty A, Huang J, Maeda N, Yotsumoto S . IFN-gamma primes RAW264 macrophages and human monocytes for enhanced oxidant production in response to CpG DNA via metabolic signaling: roles of TLR9 and myeloperoxidase trafficking. J Immunol. 2006; 176(8):5033-40. DOI: 10.4049/jimmunol.176.8.5033. View

5.
Dunn G, Koebel C, Schreiber R . Interferons, immunity and cancer immunoediting. Nat Rev Immunol. 2006; 6(11):836-48. DOI: 10.1038/nri1961. View